Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Antisense oligonucleotide targeted to the SMN2 gene

EU orphan designation number: EU/3/12/976   
Active ingredient: Antisense oligonucleotide targeted to the SMN2 gene
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: Ionis USA Limited
Tower 42 level 30, International Finance Centre, 25 Old Broad Street, EC2N RHQ London, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/04/2012 Orphan designation EMA/OD/141/11 (2012)2346 of 02/04/2012
07/04/2016 Change of name and/or address of sponsor